About Vascular Therapies
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery. Although AV grafts offer an alternative to fistula for patients with small or weak veins, it increases the risk of blood clotting, aneurysms, and infections. Sirogen™ is a bioabsorbable implant that delivers a well-known drug called sirolimus to blood vessels.
Keywords
Industries
Where is Vascular Therapies located?
The company Vascular Therapies is located in Cresskill, New Jersey, United States. It's worth noting that the company may has more corporate locations
How many employees does Vascular Therapies approximately have?
As of the latest available information Vascular Therapies has around 1-10 employees worldwide.
When was Vascular Therapies founded?
Vascular Therapies was founded in 2001
In which industries does Vascular Therapies mainly work?
The company Vascular Therapies has it's main focus in the industries of Science and Engineering, Biotechnology, Health Care
MEDA Angels
United States
1-10 Employees
2019
Vascugen
United States
11-50 Employees
2017
Cagent Vascular
United States
11-50 Employees
2014
QT VASCULAR LTD.
Singapore
11-50 Employees
2013
Verigraft AB
Sweden
11-50 Employees
2004
InnAVasc Medical
United States
1-10 Employees
2013
BVG - Bio Vascular Group
Italy
1-10 Employees
2009
TriStar Health Partners
United States
1-10 Employees
2009
Topics which have been searched by others and may be interesting for you:
